How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review
International Urogynecology Journal · 2024
DOI: 10.1007/s00192-024-05844-x ↗Kurz gefasst
Scoping Review in der Zeitschrift International Urogynecology Journal, 2024. Verfasst von Ahmed Soliman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Mansoura University, 6 Al Ashqar St., of El Gomhouria St, Mansoura, Egypt. ahmedsolimann9090@gmail.com. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Platelet-Rich Plasma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition characterized by chronic inflammation that affects the bladder. The study was aimed at evaluating the effectiveness of intravesical platelet-rich plasma (PRP) injections in patients with IC/BPS. METHODS: We conducted a comprehensive search strategy to involve studies that investigate the efficacy of intravesical PRP injections or instillations over different time intervals. Various outcome measures were assessed, including pain scores, functional outcomes, urodynamic parameters, and surface expressions on the urothelium. RESULTS: Our search strategy revealed 1,125 studies. After screening, ten articles met the inclusion criteria. Intravesical PRP significantly reduced the visual analog scale (VAS) compared with baseline scores. Several clinical trials reported significant improvements in the global response rate (GRA), O'Leary-Sant Symptom (OSS) questionnaire, Interstitial Cystitis Symptom Index (ICSI), and Interstitial Cystitis Problem Index (ICPI). Urodynamic parameters such as maximum flow rate (Qmax) and post-voiding residual (PVR) showed significant improvements in some studies. CONCLUSION: The study concluded that intravesical PRP injections could be a promising effective treatment option for IC/BPS patients by their significant ability to reduce pain. However, improvement of urodynamic and functional outcomes is still not clear. Further large comparative trials are still warranted to assess the efficacy of PRP instillation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Mansoura University, 6 Al Ashqar St., of El Gomhouria St, Mansoura, Egypt. ahmedsolimann9090@gmail.com.
- Research Department, Mansoura Research Team (MRT), Mansoura, Egypt. ahmedsolimann9090@gmail.com.
- Faculty of Medicine, Mansoura University, 6 Al Ashqar St., of El Gomhouria St, Mansoura, Egypt.
- Research Department, Mansoura Research Team (MRT), Mansoura, Egypt.
- Urology and Nephrology Center (UNC), Mansoura University, Mansoura, Egypt.
ORCID-Profile: Ahmed Soliman
Zitieren
APA
Soliman, A., Adel, M., Elnagar, M. A., Elsonbaty, S., & Hefnawy, A. E. (2024). How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review. International Urogynecology Journal. https://doi.org/10.1007/s00192-024-05844-x
Vancouver
Soliman A, Adel M, Elnagar MA, Elsonbaty S, Hefnawy AE. How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review. International Urogynecology Journal. 2024. doi:10.1007/s00192-024-05844-x
BibTeX
@article{Soliman2024,
author = {Soliman, Ahmed and Adel, Mariam and Elnagar, Mohamed A and Elsonbaty, Saif and Hefnawy, Ahmed El},
title = {How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review},
journal = {International Urogynecology Journal},
year = {2024},
doi = {10.1007/s00192-024-05844-x}
}
EUVIMED